Biomed Israel 2026 Honors Top Innovative Life Science Startups

Biomed Israel 2026, the premier international life science conference in Israel, and 8400 The Health Network, announced that Starget Pharma, caVos Biotech, Protai and BAIBYS™ are the winners of the startup showcase and competition for companies developing breakthrough technologies in the life sciences. The panel of judges was comprised of representatives of VCs and multinational pharmaceutical and device companies from the US and Israel including: Anat Naschitz, 9vc; Reut Shema, PhD, aMoon; Neta-li Feuerstein Ganor, Eli Lilly; Adar Makovski Silverstein, PhD, Arkin Bio Ventures; Yael Gruenbaum-Cohen, PhD, Entree Bio Ventures; Irit Yaniv, MD, Almeda; Joseph Korff, ARC Ventures; Yair Benita, PhD, AION labs; Peter Kash, PhD, Camelot BioCapital and Amir Blatt, JJDC.

Ruti Alon, Founder and CEO, Medstrada and Co-Chairperson, Biomed Israel, stated, "The Biomed Israel startup competition helps spotlight promising startup companies in the life sciences. We are grateful for the opportunity to assist young companies in entering the market, and to promote them with the goal of forming partnership that will eventually lead to solutions and products that will benefit millions around the world." 

Anat Naschitz, General Partner at 9VC and Reut Shema, Partner at aMoon, who headed the competition, said, "We are incredibly proud of the caliber of companies that participated in this year's competition. From nearly 100 applicants, we selected 12 finalists that reflect the breadth and diversity of innovation emerging from Israel's Life Sciences sector. Selecting the winners was no easy task, and we believe each finalist has the potential to make a meaningful impact on patients' lives and shape the future of healthcare. Their technologies embody the originality, ingenuity, and entrepreneurial spirit that continue to define Israeli innovation."

Dr. Yair Schindel, Co-founder and Chairman at 8400 and Managing Partner and Co-Founder of aMoon, added, "One of the most inspiring aspects of this competition was seeing entrepreneurs come together around a shared mission of advancing healthcare. Israel's HealthTech and lifescience ecosystem is uniquely collaborative, and organizations like 8400 and the Biomed conference play an important role in bringing the industry together in ways that make the whole far greater than the sum of its parts. Israel continues to create unique opportunities at the intersection of healthcare and technology, helping accelerate innovation and improve outcomes for patients around the world."